Eotaxin-1 levels (Figure 6) were significantly higher in the rapidly progressive cohort compared to the stable COPD group (p = 0.04) and to normal controls (p < 0.02). This evidence concerns the gene CCL11 and chronic obstructive pulmonary disease.